Skip to main content
. 2016 Jun 21;2016(6):CD010696. doi: 10.1002/14651858.CD010696.pub2

Ricci 1987.

Study characteristics
Methods Allocation: "randomisation list"
Design: parallel‐group
Participants Number: 10 analysed
Age: mean 36
Gender: 6 M, 4 F
Setting: outpatients, Italy
Eligibility criteria: Ménière's syndrome, investigator‐definedExclusion criteria: allergy to betahistine, ulcer, other medical conditions as defined
Baseline characteristics: similar baseline characteristics
Interventions Betahistine 8 mg 3 times a day versus placebo for variable duration (10 x mean duration of interval between attacks for each patient)
Intervention group:
n = 5
Comparator group:
n = 5
Use of additional interventions: none
Outcomes Primary outcome: narrative only (description of each patient's history)Secondary outcomes: none
Funding sources Not stated
Declarations of interest Not stated
Notes Participants lost to follow‐up: not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomisation list"
Allocation concealment (selection bias) Unclear risk Method not stated
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Double‐blind, but no further information
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Double‐blind, but no further information
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No information
Selective reporting (reporting bias) High risk Limited outcome data and no information on adverse events
Other bias Unclear risk